GLP-1 Drugs and Alzheimer’s Disease: What Science Says About Brain Health and Type 3 Diabetes
Can diabetes drugs protect the brain? New trials of GLP-1 medications show mixed results in Alzheimer’s disease, revealing both promise and critical limitations.